The Rotocall, Seiko references A829-A6019 and A829-A6029, debuted in 1982 when digital watches were still in their relative ...

TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Whether you're shopping for a new timepiece to add to your own ...

No doubt about it: G-Shock makes some of the toughest watches on the planet. They can survive hard drops, deep-sea diving, hell, even combat zones across some of the most demanding terrain known to ...

From disassembly and polishing to custom detailing, this restoration combines craftsmanship with creativity. The result is a ...

For the first time since it launched 36 years ago, the iconic Casio F-91W digital watch is getting some smart upgrades — but ...

The Casio CRW-001G-9JR, in its new gold colorway, serves as a distinctive fashion statement. Priced at ¥22,000 JPY (approx. $150 USD), it is available now via raffle on Casio’s website until October 6 ...

A beloved PBS kids' classic will make a comeback this fall after nearly 20 years, as "Reading Rainbow" returns to your screens with a new host. The popular children's series, once PBS's most-watched ...

President Trump, Vice-President JD Vance and other Trump administration officials are among those expected to attend and speak at the event. By Tim Chan A number of television networks are preempting ...

I was on a ferry from Minori to Salerno, basking in the majesty of a coastal sunset, with its blue-purple skies with honey-gold haloed clouds, when I got an email. GQ’s Watch Editor was checking my ...

Bad Bunny is performing at the 2026 Super Bowl LX halftime show! The Super Bowl is on Sunday, February 8, at Levi’s Stadium. The show will be airing on NBC and Peacock. After weeks of speculation, the ...

Newcastle are aiming to recover from a last-minute defeat to Arsenal as they prepare to face Belgian side Union SG in the Champions League. The Magpies have had a rocky start to the 2025/26 season, ...

AstraZeneca shares rallied on Wednesday after the U.K.-based pharmaceuticals giant and its Japanese partner said the Food and Drug Administration was reviewing one of its drugs to treat breast cancer.